U.S. Government to Cover COVID-19 Vaccine, Treatments
THURSDAY, Oct. 29, 2020 -- Insurance rules that will grant every American free access to COVID-19 vaccines when they are approved were issued by the government on Wednesday, the Associated Press reported.
The rules, from the U.S. Centers for Medicare & Medicaid Services, also increase what Medicare pays hospitals for COVID-19 treatments. The changes come as COVID-19 infections are rising across the country in a third wave that could eclipse the number of cases seen earlier this year, according to the AP. There is already legislation making the vaccines free, but the new rules were necessary to bring that legislation in line with existing insurance policies.
"CMS is acting now to remove bureaucratic barriers while ensuring that states, providers, and health plans have the information and direction they need to ensure broad vaccine access and coverage for all Americans," CMS head Seema Verma said in a statement. The regulations take effect immediately, the AP said.

© 2021 HealthDay. All rights reserved.
Posted: October 2020
Further Support and Information on COVID-19
Read this next
Certain Factors Increase Pandemic's Psychological Impact on College Students
WEDNESDAY, Jan. 27, 2021 -- Certain risk factors are associated with college students self-reporting a psychological impact of the COVID-19 pandemic, according to a study...
Retired Doctors, Nurses Will Be Approved to Give COVID-19 Vaccine, White House Says
WEDNESDAY, Jan. 27, 2021 -- Retired doctors and nurses are being called to the front lines of the U.S. COVID-19 vaccination effort, the White House COVID-19 Response team...
Respiratory, Physical, Psych Sequelae ID'd After COVID-19 Discharge
WEDNESDAY, Jan. 27, 2021 -- For patients hospitalized with COVID-19, respiratory, physical, and psychological sequelae are common at four months after discharge, according to a...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.